Nature Product as Potential Candidates to Improve Cardio-Metabolic Outcomes in Health and Disease
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 15398
Special Issue Editors
Interests: serious games; extended reality; education; healthcare
Special Issues, Collections and Topics in MDPI journals
Interests: antioxidants; obesity; diabetes; cancer; oxidative stress; autophagy; cell signaling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic disorders such as diabetes, hypertension, and obesity have increased dramatically in the last decade, not only in developed countries but also in developing countries with growing economies. As the incidence of obesity, diabetes, and hypertension have all increased, this has also resulted in a parallel increase in the prevalence of cardiometabolic consequences. Cardio-metabolic complications are complex disorders that may be influenced by a variety of factors such as changes in living environments, foods, lifestyles, genetics, and epigenetic factors. Although tremendous progress has been made in understanding the complex processes behind various cardio-metabolic problems, there is still more research to be conducted.
A substance that offers physiological benefits or provides protection against chronic illness is referred to as a natural product. Natural products can be used to promote health, prevent chronic illnesses, and maintain the body's structure and function. They have recently attracted a lot of attention because of their potential nutritional, safety, and therapeutic benefits. Furthermore, natural products may be derived from many sources, including plants, foods and even unutilized parts from plants or food. Natural products may offer their beneficial effects either in their original form or as bioactive extracts, which might be a source of therapeutic candidates for cardio-metabolic diseases. Hence, studies that uncover novel biological processes of natural products in the context of cardio-metabolic outcomes, for example, may offer new therapeutic insights for the prevention or treatment of cardio-metabolic diseases.
This Special Issue invites both reviews and original articles that elucidate the recent progress in natural products and their potential impact on cardio-metabolic health outcomes. In particular, natural products that have the potential to serve as drug candidates for cardio-metabolic diseases will be highly interested in this Special Issue. The collection of manuscripts will be published as a Special Issue of Pharmaceuticals.
Topics include but are not limited to:
- Cellular targets and biological processes of natural products;
- Drug repurposing and/or synergism with natural products;
- Novel extraction technique and characterization of bioactives from natural products;
- Upcycling of natural products derived from food waste or unutilized plant parts;
- Effects of natural products and their mechanism of action in various cardio-metabolic diseases.
Dr. Chen Huei Leo
Prof. Dr. Wei Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- metabolic diseases
- cardiovascular diseases
- vascular endothelial dysfunction
- flavonoids and polyphenolic compounds
- sustainability and upcycling
- antioxidant and oxidative stress
- anti-inflammatory
- diabetes
- hypertension
- obesity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.